What question did this study set out to answer?

September 25, 2013Open Access

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

Key Points

The study aims to evaluate the use of complement-binding capacity of donor-specific anti-HLA antibodies for risk assessment of kidney-allograft loss.
Assessed the complement-binding capacity of donor-specific anti-HLA antibodies in patients.
Identified high-risk patients based on antibody profiles.
Patients identified with high complement-binding antibodies showed increased risk for kidney-allograft loss.

Abstract

Assessment of the complement-binding capacity of donor-specific anti-HLA antibodies appears to be useful in identifying patients at high risk for kidney-allograft loss.

KI fragen

Bookmark

View Full Paper

Cite This Study

Loupy et al. (Wed,) studied this question.

synapsesocial.com/papers/69d72469424c1fc5df563bc8 https://doi.org/https://doi.org/10.1056/nejmoa1302506

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper